https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49774 Wed 31 May 2023 11:27:20 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53766 Wed 28 Feb 2024 15:55:21 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53446 Wed 28 Feb 2024 15:25:40 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45141 Wed 26 Oct 2022 13:40:54 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50461 Wed 26 Jul 2023 14:17:41 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50458 Wed 26 Jul 2023 13:35:21 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30523 Wed 17 Nov 2021 16:29:56 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51016 Wed 16 Aug 2023 09:14:24 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50696 Wed 15 May 2024 14:51:17 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48815 Wed 14 Jun 2023 10:56:22 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47156 Public Health Consequences of E-Cigarettes from the United States NASEM was accepted as reflective of evidence to mid-2017. A search for papers subsequently published in peer-reviewed journals was conducted in August 2018. A small number of robust and important papers published until March 2019 were also identified and included. Groups identified studies that extended, modified or contradicted the NASEM report. A total of 3793 papers were identified and reviewed, with summaries and draft position statements developed and presented to TSANZ membership in April 2019. After feedback from members and external reviewers, a collection of position statements was finalized in December 2019. EC have adverse lung effects and harmful effects of long-term use are unknown. EC are unsuitable consumer products for recreational use, part-substitution for smoking or long-term exclusive use by former smokers. Smokers who require support to quit smoking should be directed towards approved medication in conjunction with behavioural support as having the strongest evidence for efficacy and safety. No specific EC product can be recommended as effective and safe for smoking cessation. Smoking cessation claims in relation to EC should be assessed by established regulators.]]> Wed 14 Dec 2022 15:34:26 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51338 Wed 13 Mar 2024 14:06:52 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36573 $400 per week). Device use differed for age and income. Conclusions: Internet-based interventions appear to reach the majority of socially disadvantaged populations. It is expected that this reach will continue to grow, making internet-based interventions a potential platform for providing care to low socioeconomic individuals who smoke, however inequalities may be exacerbated for those individual without internet access. Implications: Internet use among socially disadvantaged tobacco users is moderate (58%). An internet-based smoking cessation intervention for socially disadvantaged tobacco users may be an effective intervention however, older, heavier tobacco users may not benefit as easily due to limited internet access and therefore acknowledging these limitations when developing an intervention can help to acknowledge limitation of intervention reach.]]> Wed 13 Mar 2024 09:39:20 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49845 Wed 13 Mar 2024 08:52:42 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46007 Wed 13 Mar 2024 08:48:46 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27025 Wed 09 Mar 2022 16:04:27 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24075 Wed 09 Mar 2022 16:03:38 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27831 Wed 09 Mar 2022 15:59:50 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52969 Wed 07 Feb 2024 14:54:42 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37042 Wed 07 Apr 2021 20:21:29 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36864 Wed 07 Apr 2021 20:17:21 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36376 Wed 06 Apr 2022 14:02:56 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24212 Wed 06 Apr 2022 14:01:04 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30830 Wed 04 Sep 2019 09:56:24 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34421 Wed 04 Sep 2019 09:55:56 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33622 Wed 04 Sep 2019 09:47:46 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52144 Wed 04 Oct 2023 10:14:31 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28950 Wed 02 Oct 2019 10:32:51 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30534 Wed 02 Oct 2019 10:31:34 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36091 Wed 02 Mar 2022 14:27:33 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36127 50%) is detected, DerSimonian & Laird inverse-variance random effects model. Pooled estimates and 95% CIs will be calculated for overall participant retention rates and for intervention and control trial arms separately. Associations between participant retention and participant, environmental, researcher and study factors will be assessed via subgroup analyses and, where sufficient data are obtained, meta-regression. Ethics and dissemination: This study does not require ethical approval. The findings of this review will be disseminated via publication in a peer-reviewed open access medical journal and presentations at international scientific meetings.]]> Wed 02 Mar 2022 14:25:31 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52910 Wed 01 Nov 2023 09:23:26 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48620 Tue 28 Mar 2023 10:04:21 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36179 Tue 25 Feb 2020 09:45:32 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:13833 Tue 24 Aug 2021 14:29:46 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49597 Tue 23 May 2023 13:34:14 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54873 Tue 19 Mar 2024 19:32:59 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52554 Tue 17 Oct 2023 15:34:23 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41737 Tue 14 Nov 2023 12:57:17 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49884 Tue 13 Jun 2023 12:05:50 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47082 Tue 13 Dec 2022 16:28:39 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44326 Tue 11 Oct 2022 16:26:45 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44312 Tue 11 Oct 2022 16:19:41 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47397 Tue 08 Aug 2023 15:46:10 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36394 Tue 07 Apr 2020 15:53:48 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54130 Tue 06 Feb 2024 11:36:31 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43867 Tue 04 Oct 2022 12:28:45 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51330 Thu 31 Aug 2023 15:36:50 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37819 Thu 31 Aug 2023 15:17:23 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28392 Thu 28 Oct 2021 13:04:50 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45132 Thu 23 Mar 2023 09:49:21 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36959 Thu 23 Jul 2020 09:03:42 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49994 Thu 22 Jun 2023 14:19:51 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54905 Thu 21 Mar 2024 11:56:02 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38243 Thu 19 Aug 2021 09:33:31 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27028 Thu 17 Mar 2022 14:41:44 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30961 Thu 17 Mar 2022 14:35:15 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39641 Thu 16 Jun 2022 14:27:07 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30585 Thu 14 Apr 2022 11:02:45 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37072 Thu 13 Aug 2020 12:47:43 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:6994 Thu 13 Aug 2020 08:46:20 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37413 Thu 12 Nov 2020 17:03:51 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46922 Thu 08 Dec 2022 09:05:52 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35723 Thu 07 Nov 2019 10:09:17 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48807 n = 65,736). Intervention effectiveness was found in the short term for all outcome measures (OR = 1.29, 95% CI 1.12, 1.50, p = .001), for "prolonged abstinence" (OR = 1.43, 95% CI 1.09, 1.87, p = .009), and "30 day PPA" (OR = 1.75, 95% CI 1.13, 2.72, p = .013). Internet-based programs were effective in the long term for all outcome measures (OR = 1.19, 95% CI = 1.06, 1.35, p = .004) and for "prolonged abstinence" (OR = 1.40, 95% CI 1.19, 1.63, p < .001). On average, interventions used more BCTs than comparison groups (6.6 vs. 3.1, p = .0002). The impact of specific individual BCTs and BCT domains on effectiveness was examined and is reported. Conclusions: Internet-based smoking cessation interventions increased the odds of cessation by 29 per cent in the short term and by 19 per cent in the long term. Internet-based smoking cessation intervention development should incorporate BCTs to increase effectiveness. Registration: CRD42015014676.]]> Thu 06 Apr 2023 16:24:35 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30161 Thu 04 Nov 2021 10:38:17 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49716 Mon 29 May 2023 14:59:51 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38817 Mon 29 Jan 2024 18:03:17 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48677 Mon 27 Mar 2023 14:18:53 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44914 Mon 24 Oct 2022 16:24:26 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44782 Mon 24 Oct 2022 09:10:26 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32022 Mon 23 Sep 2019 12:57:03 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32314 Mon 23 Sep 2019 12:52:02 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32327 Mon 23 Sep 2019 11:37:40 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25863 Mon 23 Sep 2019 10:43:35 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32684 Mon 23 Sep 2019 10:31:49 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47512 Mon 23 Jan 2023 12:15:33 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47478 Mon 23 Jan 2023 11:33:30 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27929 Mon 20 Mar 2023 12:45:15 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46279 Mon 14 Nov 2022 15:35:09 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36221 Mon 06 Apr 2020 10:08:31 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36960 Mon 03 Jul 2023 14:35:23 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40198 Mon 01 Aug 2022 08:52:32 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45490 Fri 28 Oct 2022 15:46:27 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47759 Fri 27 Jan 2023 10:39:46 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42589 Fri 26 Aug 2022 10:46:16 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51938 5 considered favorable). Discussion: This study demonstrated the feasibility and acceptability of a consumer-informed, non-face-to-face intensive tobacco treatment, highlighting the potential of remotely delivered technology-based CM to reduce the health impact of tobacco smoking in high-priority populations. The intervention demonstrates scale-up potential. Future studies should extend treatment into the postpartum period, utilizing new technologies to enhance CM delivery and improve counseling provision and partner support. Clinical Trial Registration: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374196, ACTRN1261800056224.]]> Fri 22 Sep 2023 13:27:13 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48467 Fri 17 Mar 2023 13:08:29 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47247 Fri 16 Dec 2022 12:29:36 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49354 Fri 12 May 2023 12:28:36 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46123 Fri 11 Nov 2022 15:07:56 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52989 Fri 03 Nov 2023 16:07:34 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52988 Fri 03 Nov 2023 16:07:10 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52971 Fri 03 Nov 2023 15:31:52 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31395 N = 754) were randomised to receive either usual care (n = 375) or an intervention comprising a brief mot ivational interview and self-help material while in hospital, followed by a 4-month pharmacological and psychosocial intervention (n = 379) upon discharge. Primary outcomes assessed at 6 and 12 months post-discharge were 7-day point prevalence and 1-month prolonged smoking abstinence. A number of secondary smoking-related outcomes were also assessed. Subgroup analyses were conducted based on psychiatric diagnosis, baseline readiness to quit and nicotine dependence. Results: Seven-day point prevalence abstinence was higher for intervention participants (15.8%) than controls (9.3%) at 6 months post-discharge (odds ratio = 1.07, p = 0.04), but not at 12 months (13.4% and 10.0%, respectively; odds ratio = 1.03, p = 0.25). Significant intervention effects were not found on measures of prolonged abstinence at either 6 or 12 months post-discharge. Differential intervention effects for the primary outcomes were not detected for any subgroups. At both 6 and 12 months post-discharge, intervention group participants were significantly more likely to smoke fewer cigarettes per day, have reduced cigarette consumption by 3/450% and to have made at least one quit attempt, relative to controls. Conclusions: Universal smoking cessation treatment initiated in inpatient psychiatry and continued post-discharge was efficacious in increasing 7-day point prevalence smoking cessation rates and related quitting behaviours at 6 months post-discharge, with sustained effects on quitting behaviour at 12 months. Further research is required to identify strategies for achieving longer term smoking cessation.]]> Fri 03 Dec 2021 10:34:17 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37807 Fri 03 Dec 2021 10:33:33 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36382 Fri 03 Apr 2020 15:56:33 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36375 Fri 03 Apr 2020 15:49:50 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42775 Fri 02 Sep 2022 11:00:17 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39989 N = 378 participated. Response rates 8.4% (N = 42; online survey) and 6% (N = 335; paper survey), respectively. Total percentages agreeing with system-based changes: 79% training, 64% oral NRT subsidy, 62% Medicare item for smoking cessation, 54% improved access to NRT patches. Within RANZCOG, more GPs (73.1%) agreed that oral NRT should be subsidised (P = 0.001) than obstetricians (53.7%). Conclusion: GPs and obstetricians agreed that system changes would improve their management of smoking in pregnancy. Oral NRT subsidy was the only pairwise group difference. Subsequently, oral NRT has been subsidised; in time, this may influence prescribing and quit rates.]]> Fri 01 Jul 2022 13:00:40 AEST ]]>